CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Samsung Biologics Co Ltd Company Snapshot
Samsung Biologics Co Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Samsung Biologics Co Ltd with three other pharmaceutical manufacturers in Asia: Hualan Biological Engineering Inc of China (2017 sales of 2.37 billion Chinese Renmimbi [US$345.37 million] of which 88% was Blood Product), Tonghua Dongbao Medicines Company Limited of China (2.54 billion Chinese Renmimbi [US$370.64 million] of which 89% was Pharmaceutical), and China Biologic Products Holdings Inc which is also based in China (2.49 billion Chinese Renmimbi [US$363.82 million] of which 100% was Human Blood Product).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Samsung Biologics Co Ltd
  Stock Performance Chart for Samsung Biologics Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/14/2018): 334,500
(Figures in Korean Won)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
 
Samsung Biologics Co Ltd Key Data:
  Ticker: 207940 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 464,629,334,143
(Year Ending Jan 2018).
Employees: 2,119
  Currency: Korean Won Market Cap: 22,132,192,500,000
  Fiscal Yr Ends: December Shares Outstanding: 66,165,000
  Share Type: Common Closely Held Shares: 49,787,603
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.